日本老年人骨质疏松和大动脉狭窄风险:基于人口的嵌套病例对照研究
Takuya Uematsu1, Yusuke Hirabuki2, Shuko Nojiri3
1Clinical Translational Science, Juntendo University School of Medicine Graduate School of Medicine, Tokyo, Japan; Department of Hospital Pharmacy, Juntendo University Shizuoka Hospital, Shizuoka, Japan.
Journal of cardiology
|July 4, 2025
概括
这项研究发现,在日本,大动脉狭窄症 (AS) 和骨质疏松症之间没有显著的联系. 需要对利尿剂和其他影响AS的因素进行进一步的研究.
科学领域:
- 老年学是指老年学的学科.
- 心血管医学 心血管医学
- 骨的新陈代谢 骨的新陈代谢
背景情况:
- 大动脉狭窄 (AS) 在老年人中很常见,与衰老和代谢有关.
- 以前的研究表明,AS和骨质疏松症在全球和日本之间存在不一致的关联.
- 这项研究调查了日本老龄化人口中的骨质疏松症-AS关系.
研究的目的:
- 确定日本老年人骨质疏松症和大动脉狭窄症 (AS) 之间的关联.
- 分析现实世界的数据,以澄清老年医学中潜在的辩论关系.
主要方法:
- 一项嵌套病例控制研究利用了日本一百一十六万个人的行政数据库.
- 病例 (AS) 和对照组根据年龄和性别与1:1匹配.
- 条件后勤回归估计了AS患者骨质疏松症的几率比率,并对共变量进行调整.
主要成果:
- 在大动脉狭窄和骨质疏松症之间没有发现显著的关联 (OR 0.887,95% CI 0.778-1.01).
- 观察到与糖尿病,慢性病,高血压和脂质不良症有显著的关联.
- 利尿剂的使用,特别是在老年人中,与AS有显著的关联.
结论:
- 来自100多万个人的现实数据表明,AS和骨质疏松症之间没有联系.
- 建议进行进一步的研究,以探索利尿剂对AS的影响.
- 需要对其他导致AS与骨质疏松症关系的因素进行全面分析.
相关概念视频
Bone Disorders
4.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
4.0K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
41
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
41
Atherosclerosis III: Management
41
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
41
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
59
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
59
Aortic Regurgitation III: Medical Management
51
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
51
Coronary Artery Disease IV: Preventive Measures
38
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
38


